AbbVie Inc at Barclays Global Healthcare Conference Transcript
Good morning, and welcome to Day 3 of the Barclays Global Healthcare Conference. We're in the home stretch here. My name is Carter Gould. I cover U.S. BioPharma. I'm very pleased to welcome AbbVie to the stage. We have a full house here incoming CEO, Rob Michael, is here; as well as Scott, Jeff and Roopal across finance, commercial and development. Thank you all for joining us.
Thank you for having us.
Questions & Answers
Plenty to dig into here. AbbVie was one of our top picks for the year. So we're absolutely excited to have you guys on stage. Maybe Rob to start historically, AbbVie, I think, has been characterized as under investing in R&D, at least as relative to its sales. We've talked in pretty forceful language around how that's changed more recently. I think one of the questions is that now as you
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
